相关实验视频

Updated: Sep 13, 2025

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

一种化狄基托皮佩拉辛抗生素向着Mycobacterium结核病菌

Libang Liang¹, Jeffrey Quigley¹, Monique Theriault¹

¹Department of Biology, Antimicrobial Discovery Center, Northeastern University, Boston, Massachusetts, USA.

Antimicrobial agents and chemotherapy

|July 31, 2025

概括

一种新的化合物 - - 斯佩罗巴克,可以选择性地向并杀死Mycobacterium tuberculosis. 这种新型抗生素通过抑制DNA旋转酶 (DNA gyrase) 起作用,这种酶对细菌的生存至关重要.

科学领域:

微生物学微生物学
生物化学生物化学
药物发现药物发现药物发现

背景情况:

结核菌菌 (M. tuberculosis) 构成一个重大的全球健康威胁,需要新的治疗策略.
耐药菌株的出现进一步使治疗复杂化,凸显出迫切需要新的抗结核剂.

研究的目的:

确定和描述一种新型抗微生物化合物,该化合物对M. tuberculosis有效.
阐明这种新化合物的作用机制和分子标.

主要方法:

从Photorhabdus temperata中分离和表征斯皮罗巴克.
对M.结核病突变的基因组分析,这些突变对speirobactin.
重建已识别的突变以确认分子标.
用speirobactin治疗的M.结核病的转录组分析.

主要成果:

发现了speirobactin,一种具有针对M.结核病的选择性活性的宏环.
通过基因组和突变分析,确定DNA回旋酶作为斯皮罗巴克的唯一分子标.
转录组数据支持斯皮罗巴克的作用机制,与诺基诺隆聚合,这也针对DNA旋转酶.

结论:

斯佩罗巴克代表了一种有前途的新疗法候选药物,用于治疗结核病.
鉴定DNA回旋酶为标,为开发新的抗结核药物提供了可验证的方法.
了解耐药机制可以为未来的药物开发策略提供信息.

关键词:

DNA 旋转酶 DNA 旋转酶抗微生物药物是一种抗微生物药物.发现药物的发现.结核病是一种肺结核病.

更多相关视频

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments

Published on: October 25, 2024

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

相关概念视频

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

Pulmonary Tuberculosis IV

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...